“Light Therapy Platform System”, U.S. Patent Publication No. US 2013-0066404 A1, published on Mar. 14, 2013, by Tapper et al., the disclosure of which is incorporated herein by reference in its entirety.
The present embodiments relate to devices and methods for delivering light-based skin therapy treatments for improving skin health, and/or relieving subdermal tissue using light-emitting diode (LED) light therapy, although other types of light radiating sources can be used.
Certain light spectrums emitted by LEDs (blue or red) are known to be therapeutic for skin treatment by being beneficial to better factor wound healing or relieving muscular or other subdermal tissue pain. However, there is a need to provide users/patients with a convenient at-home light therapy delivery device such as a wearable bandage that is adjustable or flexible to conform to different sizes and shapes, and that is simple to use without user discomfort. The alternative is visiting a doctor's office to receive treatments.
Prior known light therapy devices have suffered from problems relating to the exposure of the LEDs and the associated circuitry to power the LEDs to contact by users. More particularly, in an effort to maximize light communication to a patient, the LEDs have been disposed in a manner which allow them to be physically engaged (e.g., touched) by a patient, or even contact a treatment surface, which processes are debilitating to the LEDs as a result of the accumulation of dirt and oil. In addition, any such engagement can be potentially dangerous to patients who are exposed to the sharp or hot edges of the LEDs and the associated circuitry. The exposure of detailed circuitry presents an intimidating and unpleasant experience.
Another problem with prior known devices is that the LED arrangement is fixed and not adjustable to better correspond to wound location, size or shape, or to be better placed relative to pain areas. The LEDs of such devices are not selectively arrangeable in a variety of patterns to better enable the application of the device near particular pain areas of a wound.
It is desired to provide alternative means of using the benefits of the light therapy in a manner to maximize therapeutic efficiencies in exposure while maintaining ease and convenience of use. For this reason, a variety of light weight, flexible and adjustable embodiments are disclosed within this disclosure incorporating a variety of energy varying applications responsive to user conditions or needs.
According to an exemplary embodiment of this disclosure, provided, a phototherapy system and device includes a therapeutic lamp platform for radiant lamps such as LEDs which are disposed in an assembly comprising a multi-layer structure wherein the LEDs are guarded from patient contact.
The exemplary embodiments disclosed provide an adjustable/flexible platform for providing a light-based therapy that is adaptable to the user's receptive surfaces, i.e., treatment areas, whether based on size or condition, wherein the light therapy can be applied without limitation of the kind of light and without limitation of the ultimate purpose of the therapy, i.e., beauty, health, pain relief and/or wound healing. Such sources can vary in the form of the radiant energy delivery. Pulsed light (IPL), focused light (lasers) and other methods of manipulating light energy are encompassed within the presently disclosed embodiments. Other methods of light emission may include continuous, pulsed, focused, diffuse, multi wavelength, single wavelength, visible and/or non-visible light wavelengths.
According to an exemplary embodiment of this disclosure, forms such as a shaped/fitted bandage with LED light emitted from LED bulbs or LED strips that are capable of being adjusted to accommodate variances in a desired treatment area.
According to one exemplary embodiment of this disclosure, a phototherapy device is provided which includes a stretchable and/or flexible wearable therapeutic lamp platform including a plurality of radiant lamps configured to provide radiant energy to a user treatment area; a stretchable and/or flexible reflective wall including a plurality of radiant energy communication areas aligned with the radiant lamps and disposed to communicate the radiant energy to the user treatment area; and a stretchable and/or flexible adhesive layer including a first surface and a second surface, the first surface removably attached to the reflective layer and the second surface operatively associated with removably attaching the wearable therapeutic lamp platform to the user treatment area.
According to another exemplary embodiment of this disclosure, provided is a stretchable and/or flexible wearable phototherapy device including a plurality of radiant energy pods, each pod including one or more radiant lamps to provide radiant energy to a user treatment area, and each pod stretchably and flexible connected to one or more other pods; and a control pod stretchably and flexibly connected to one or more radiant energy section, the control pod operatively connected to the radiant energy pods and configured to control an operation of the radiant lamps.
The present disclosure thus describes a fully stretchable and/or flexible and adjustable LED device which provides improved usability and light dispersion. Such a device includes a light therapy bandage system including a spacing and/or insulating layer to effectively elevate the lamp radiation from the patient's treatment area (e.g. skin). According to one exemplary embodiment, the lamps are recessed relative to the insulating layer and further covered by a sheer mesh layer to protect the user from being able to contact the lamps. Moreover, the disclosed embodiments may or may not be used with lotions, creams and/or ointments which enhance the efficacy of the delivered phototherapy radiation to provide treatment to a user treatment area.
The subject embodiments relate to a phototherapy system including methods and devices, preferably comprising a wearable device integrated with a portable battery pack for powering therapeutic lamps in the device. The subject devices display numerous benefits including a light platform wherein the platform and the lamps therein are properly positionable relative to a user treatment area during use, where no human touch is required during treatment. That is, structural componentry of the device not only supports the lamp platform on the user, but functions as a guide for the appropriate disposition of the lamps relative to the treatment areas of the user. The structural assembly of the device precludes sharp or hot surfaces from being engageable by a user as the lamps are recessed relative to an inner reflective surface nearer to and facing the patient treatment surface. Circuit componentry to communicate power to the lamps is also encased within a flexible and stretchable wall structure. Therapeutic light, shining through wall radiant energy communication areas, such as, but not limited to, apertures, mesh and clear/translucent layers, is communicated to the user while the lamps and the circuitry are effectively covered within the layered wall structure. A surface is thus presented to the user that is properly spaced for the desired therapeutic treatments, yet provides improved ventilation so that an aesthetic and appealing device surface is presented to the user that minimizes user discomfort. Other benefits relate to the adjustability of the device in the form of a bandage which forms upon user receipt to match a treatment surface, e.g., back or knee, of the user. The overall assembly is purposefully constructed of relatively light weight and minimized componentry for ease of user use and comfort.
More particularly, and with reference to
In one exemplary embodiment, the mesh cloth allows communication of the lamp radiation through to the patient without reflection.
In another exemplary embodiment, the flexible formable material 24 has apertures (not shown) functioning as a window to allow the light to pass through and the remainder of the material 24 includes a light reflective surface. In this embodiment, the LEDs are effectively hidden from the patient, where layer 24 is a mesh cloth where the patient can see the LEDs tips and the associated circuitry.
The subject system may also include control systems to vary light intensity, frequency or direction. A portable battery pack is integrated to the wearable phototherapy device, and may include a removable replaceable battery pack or a rechargeable battery pack.
The subject adjustability can be implemented through “smart” processing and sensor systems for enhanced flexibility/adjustability in the form of adjustable energy output, adjustable wavelengths, priority zones, timers, and the like. The sensors of the sensor systems enable the subject embodiments to have the ability to evaluate the treatment area and plan a smart treatment, utilizing more or less energy on the priority zones. The subject embodiments can also be smart from the standpoint of body treatment area such as knee or back, and of skin type, age, overall severity of problems and have the ability to customize the treatment accordingly.
In yet another exemplary embodiment, the lamps are embedded in a flexible sheet of formable material and are integrally molded as strips within a material sheet.
With reference to
With reference to
In other embodiments, the LED strip pattern can be arranged in different placements as shown in the figures to better match treatment to the desired patient treatment area. For example, rather than being equally spaced, the strips can be bunched together in a group, or several groups, where the bandage material is constructed of a material that allows the LED strips to be selectively moved and then affixed to the material at different locations, for example, hook-and-loop fastening fabric.
The controller 74 is configured to communicate operational aspects of the device to the user in several ways. When the user actuates an ON switch, an indicator such as a light or beep sounder lets the user know that the device is operating. The controller times the operation to a predetermined limit such as 10 or 15 minutes. In addition, the controller counts usage or cycle sessions to indicate to the user via a controller display, the number of sessions that have been provided by the device and additionally, to disable the device after the LED efficiency in generating therapeutic radiation has been diminished from prior sessions such that the device should no longer be used. The controller also deactivates the indicator light after the session duration has been timed out or may alternatively send another sound beep to the user. Alternatively, the indicator can also provide for indicating battery life or lamp failure.
With reference to
While the exemplary embodiment described with reference to
As shown in
With reference to
As shown, the heating element 118 is arranged in a pattern which covers the general shape of the phototherapy device and provides heat to a user treatment area. Essentially a wire, such as a Nichrome® wire driven by the controller 108 provides heat and temperature sensors 119 provide feedback to the controller 108 to regulate the radiated heat provided to the user treatment area, in addition to ramping up the initial heat provided after the phototherapy device is turned ON, for example ramping quickly to maintain a temperature between 40-45 Celsius.
The structure of the phototherapy device provides a stretchable, flexible and conformable, therapeutic lamp platform which can be applied to a variety of user treatment areas. In other words, the phototherapy device is conformable to user treatment area in three dimensions.
With reference to
The reflective layer includes a plurality of lamp radiation communication areas 121, such as apertures, clearance holes and/or areas of the reflective layer 122 aligned with the LEDs which are transmissive to the wavelength of the radiation emitted from the LEDs. In other words, the lamp radiation communication areas can be made of a clear or translucent flexible material, where a reflective layer or film, such as a reflective metal foil or PET reflective material is applied to the bottom, i.e. reflective surface of the reflective layer 122, using a masking process to maintain the radiation transmissive characteristics of the radiation communication areas 121. In addition to reflecting lamp radiation, the reflective layer 122 material can include insulating material to contain heat within the user treatment area for effectively treating pain, etc.
As an alternative arrangement, the phototherapy device can integrate the reflective layer 122 with a biomedical sticky gel as a single usable substrate. In other words, the sticky gel, which is replaceable by a user, would include a replaceable reflective layer incorporated into the sticky gel, where a reflective material is encased within the sticky gel.
Sticky gel is a “sticky” adhesive gel compound which removably adheres to the phototherapy device structure reflective layer 122 and a user treatment area. The sticky gel layer is made of a material which also is substantially transparent to the LED lamp radiant emitted by the phototherapy device or includes apertures to communicate the LED lamp radiation. Examples of a suitable material include silicon, hydrogel acrylic and urethane based material.
According to an exemplary embodiment, the sticky gel component includes multiple layers integrated into a single replaceable structure, where a top layer material has properties to provide a bond to the phototherapy device structure and a bottom layer material has properties to provide desirable adhesive properties to a user treatment area. In addition, a third layer material between the top and bottom layers can be provided to act as a structural component to maintain the form of the sticky gel component.
With reference to
The flexible and stretchable top layer 114 and bottom layer 120 provide a flexible and stretchable housing for LED strips 116, wires 117, an optional heating element 118 and optional temperatures sensors 119. The stretchable layers 114 and 120 can be made from, for example, a low durometer silicone TPE, and/or fabric. As shown in
With reference to
The LED strips 116 include a plurality of LEDs which are operatively connected by wires 117. According to an exemplary embodiment, 18 LEDs of two different wavelengths are provided, where 6 LEDs provide IR (Infrared Spectrum Radiation) for inflammation relief and 12 LEDs provide R (Red Spectrum Radiation).
With reference to
With reference to
As shown, included are two batteries 106, a controller 108 and wires 110 which operatively connect batteries 106 to the controller 108. A suitable length of wires 110 provides a stretchable and flexible configuration where the wires 110 are free to expand and contract while maintaining electrical conductivity between the controller 108 and batteries 110, as well as between the controller 108 and LED strips 116.
With reference to
With reference to
With reference to
With reference to
With reference to
With reference to
With reference to
With reference to
With reference to
With reference to
With reference to
With reference to
After a user removes the used sticky gel component from the phototherapy device, the user initially places the phototherapy device bottom-side-up in the docking area of the carrier 300 shown.
Next, at step 2, the user removes an unused sticky gel component 124 from the carrier 300 and places the unused sticky gel component on the phototherapy device as shown in step 3.
Finally, the user applies pressure to the sticky gel component backing layer 302 to adhere the sticky gel component to the phototherapy device as shown at step 4.
Possible adhesive gel carrier designs include a boot package similar to a foldable travel case, roll type packaging where a user unrolls the package to remove the next adhesive gel, and a pencil case package.
With reference to
As shown, the phototherapy device 400 includes a plurality of soft surface pods 402, a plurality of expandable LED wire encasements 404, a controller 406 and a SIM Card device 408, which is used to activate the phototherapy device to provide a predetermined number of dosages of light therapy treatment, for example, 2-100 or any other number of dosages/sessions, including an unlimited number of treatments.
According to one exemplary embodiment, the SIM Card is a consumable product purchased by a user to provide a limited number of treatments before being required to purchase another SIM Card or electronically purchase the additional dosages for the depleted SIM Card.
As shown, the phototherapy device 480 includes a plurality of soft surface pods 482 operatively interconnected by a plurality of expandable LED wire encasements 484 and a controller 486.
As shown, the phototherapy device 500 includes a plurality of hard surface pods 502 and a controller pod 504, where the device emits therapeutic lamp radiation 506.
As shown, the adhesive layer construction 508, i.e. sticky gel component, includes an adhesive layer 510 for attaching to the phototherapy device, a mid-layer structural layer 512 and an adhesive layer for the skin 514 of the user treatment area.
As shown, the soft surface pod 482 is operatively connected to an expandable LED wire encasement 484 where the radial configuration provides for flexibility and stretchability of wires 516 which drive the LEDs.
As shown, the phototherapy device 600 includes handles 602, a flexible stretchable layer 604, LED strips 606 and an ON/OFF control switch encasement.
As shown, included is a first adhesive pad portion 710 and a second adhesive pad portion 712. Adhesive pads 710 and 712 include an adhesive layer 714 to attach to the phototherapy device structure, a mid-layer structural component 716 and an adhesive layer 718 for attaching to the skin.
With reference to
Initially at step S802, the phototherapy device is under power and operates in a Sleep Mode with the LCD display off.
During Sleep Mode, the control program executes a CM & PLD (Charge Manager and Power LED Display) subcontrol program S804, as shown in
Next, the control program executes a Refill and LCD Display subcontrol program S806, as shown in
Next, at step S808, the control program monitors the control ON/OFF button to determine if the ON/OFF button is pushed for 1 second. If not, the control program returns to step S802. If yes, the control program next executes step S810 to determine if the device has remaining dosages available.
If the dosage counter is zero, then the control program executes step S812 and blinks the dose value of “0” on the LCD to notify the user that no dosages are available. If there are remaining dosages, the control program executes step S814 to perform a Start Check subcontrol as shown in
If the Start Check subcontrol program is not executed satisfactorily, the control program returns to step S802.
After the Start Check subcontrol program is executed successfully, the control program executes step S816 to display the dose number, step S818 and S820 to ramp-up the LED to full power in 0.5 seconds, executes CM & PLD subcontrol program S822, step S824 to beep the buzzer once, and step S826 to start a 15 minute dosage session counter.
Next, at step S828, the control program monitors the dosage session counter until the active dosage session is completed, at which time step S832 beeps the buzzer twice and, at step S830, LED power is blinked for 1 second S834, both steps S832 and S830 notifying the user the currently active dosage session has been completed.
Next, the control program executes step S844 to ramp down LED power in 0.5 seconds, then the control program executes step S850 to shut off the LEDs, step S852 to shut off power to the LEDs, and step S854 to display available number of doses to the user, which is one less than previously available and displayed at step S816.
Next, the control program reviews Sleep Mode at step S802.
If, at step S828, the control program has not yet reached the end of the current active dosage session, the control program executes step 834 to monitor the ON/OFF button state, where, if the ON/OFF button is not pressed for 1 second, the control program executes subcontrol program System Check at step S836 and subcontrol program CM & PLD control program at step S838 until the current active dosage session is completed.
In the event the user presses the ON/OFF button for 1 second during the dosage session, the control program terminates the current active dosage session by executing step S840 to beep the buzzer three times and step S842 to blink the LED power for 1 second, and then executes steps S844, S850, S852 and S854 as previously described.
Initially, at step S836, the system Check Start subcontrol program S836 is executed and if not completed successfully, the subcontrol program performs step S862 to blink the LCD display and LED power to notify user at the failure, and returns to main program at step S864 indicating “NO” passage of Start Check.
After the successful completion of step S836, the subcontrol program executes step S866 to determine if there is enough battery power/charge to complete a phototherapy dose; if there is not, the subcontrol program blinks the LEDs 5 times fast to notify the user and returns to the main program at step S864.
The system Check Start subcontrol program monitors LED power draw at step S882 and after the LED power is greater than 450 mA, indicating a proper dosage radiant energy amount, the subcontrol program returns to the main program at S886 to continue executing the main control program to provide a dosage, otherwise a “NO” is returned at step S884 until adequate power is drawn by the LEDs.
Initially, the subcontrol program S804 determines if the charge cord is plugged in at step S892. If the charge cord is not plugged in, step S900 is executed to determine if the power is ON, and, if it is, the LEDs are powered at step S902, and, at step S898, the CM & PLD subcontrol program is exited. If the power is determined to be OFF at step S900, the CM & PLD subcontrol program is exited at step S898.
If the charge cord is determined to be plugged in at S892, the subcontrol program determines at step S894 if the battery is fully charged. If YES, step S904 maintains charge and the power ON LED is illuminated and step S898 is performed to exit the CM & PLD subcontrol program. If the battery is determined to require charging at step S894, the subcontrol program executes step S896 to charge the battery while pulsating the power LED until the device is fully charged.
After completion of the battery charging step S896, the subcontrol program performs step S898 to exit the CM & PLD subcontrol program.
Initially, the subcontrol program determines if the dosage number is equal to 0. If it is equal, step S924 is executed to determine if a refill cartridge is plugged in the device. If no refill cartridge is available, the subcontrol program executes step S916 to blink the dose value on the display to notify the user a refill is required.
After step S924 determines a refill cartridge is available, step S926 determines if the refill cartridge is authorized. If the refill cartridge is not authorized, steps S928 and S930 are executed to disable the refill cartridge. If the refill cartridge is determined to be authorized, the subcontrol program executes step S932 to display the addition of the refill doses amount and step S934 displays the total number of available doses for 10 seconds to the user.
At step S918, the subcontrol program monitors the ON/OFF button and if the ON/OFF button is not pressed, the subcontrol program exits at step S922. If the ON/OFF button is pressed for 1 second, step S920 is executed to display on the LCD the dose value for 10 seconds and then performs step S922 to exit the subcontrol program.
Some portions of the detailed description herein are presented in terms of algorithms and symbolic representations of operations on data bits performed by conventional computer components, including a central processing unit (CPU), memory storage devices for the CPU, and connected display devices. These algorithmic descriptions and representations are the means used by those skilled in the data processing arts to most effectively convey the substance of their work to others skilled in the art. An algorithm is generally perceived as a self-consistent sequence of steps leading to a desired result. The steps are those requiring physical manipulations of physical quantities. Usually, though not necessarily, these quantities take the form of electrical or magnetic signals capable of being stored, transferred, combined, compared, and otherwise manipulated. It has proven convenient at times, principally for reasons of common usage, to refer to these signals as bits, values, elements, symbols, characters, terms, numbers, or the like.
It should be understood, however, that all of these and similar terms are to be associated with the appropriate physical quantities and are merely convenient labels applied to these quantities. Unless specifically stated otherwise, as apparent from the discussion herein, it is appreciated that throughout the description, discussions utilizing terms such as “processing” or “computing” or “calculating” or “determining” or “displaying” or the like, refer to the action and processes of a computer system, or similar electronic computing device, that manipulates and transforms data represented as physical (electronic) quantities within the computer system's registers and memories into other data similarly represented as physical quantities within the computer system memories or registers or other such information storage, transmission or display devices.
The exemplary embodiment also relates to an apparatus for performing the operations discussed herein. This apparatus may be specially constructed for the required purposes, or it may comprise a general-purpose computer selectively activated or reconfigured by a computer program stored in the computer. Such a computer program may be stored in a computer readable storage medium, such as, but is not limited to, any type of disk including floppy disks, optical disks, CD-ROMs, and magnetic-optical disks, read-only memories (ROMs), random access memories (RAMs), EPROMs, EEPROMs, magnetic or optical cards, or any type of media suitable for storing electronic instructions, and each coupled to a computer system bus.
The algorithms and displays presented herein are not inherently related to any particular computer or other apparatus. Various general-purpose systems may be used with programs in accordance with the teachings herein, or it may prove convenient to construct more specialized apparatus to perform the methods described herein. The structure for a variety of these systems is apparent from the description above. In addition, the exemplary embodiment is not described with reference to any particular programming language. It will be appreciated that a variety of programming languages may be used to implement the teachings of the exemplary embodiment as described herein.
A machine-readable medium includes any mechanism for storing or transmitting information in a form readable by a machine (e.g., a computer). For instance, a machine-readable medium includes read only memory (“ROM”); random access memory (“RAM”); magnetic disk storage media; optical storage media; flash memory devices; and electrical, optical, acoustical or other form of propagated signals (e.g., carrier waves, infrared signals, digital signals, etc.), just to mention a few examples.
The methods illustrated throughout the specification, may be implemented in a computer program product that may be executed on a computer. The computer program product may comprise a non-transitory computer-readable recording medium on which a control program is recorded, such as a disk, hard drive, or the like. Common forms of non-transitory computer-readable media include, for example, floppy disks, flexible disks, hard disks, magnetic tape, or any other magnetic storage medium, CD-ROM, DVD, or any other optical medium, a RAM, a PROM, an EPROM, a FLASH-EPROM, or other memory chip or cartridge, or any other tangible medium from which a computer can read and use.
Alternatively, the method may be implemented in transitory media, such as a transmittable carrier wave in which the control program is embodied as a data signal using transmission media, such as acoustic or light waves, such as those generated during radio wave and infrared data communications, and the like.
It will be appreciated that variants of the above-disclosed and other features and functions, or alternatives thereof, may be combined into many other different systems or applications. Various presently unforeseen or unanticipated alternatives, modifications, variations or improvements therein may be subsequently made by those skilled in the art which are also intended to be encompassed by the following claims.
This application is a continuation-in-part of U.S. patent application Ser. No. 14/212,601, filed Mar. 14, 2014, which claims priority to U.S. Provisional Patent Application Ser. No. 61/791,738, filed Mar. 15, 2013, and this application is a continuation-in-part of U.S. patent application Ser. No. 14/324,453, filed Jul. 7, 2014, which is a divisional of U.S. patent application Ser. No. 13/604,012, filed Sep. 5, 2012 now U.S. Pat. No. 8,771,328, which claims priority to U.S. Provisional Patent Application Ser. No. 61/532,140, filed Sep. 8, 2011, the disclosures of which are incorporated herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
1626617 | Last | May 1927 | A |
1692669 | Last | Nov 1928 | A |
3279468 | Le Vine | Oct 1966 | A |
3376870 | Yamamoto et al. | Apr 1968 | A |
3971387 | Mantell | Jul 1976 | A |
5085227 | Ramon | Feb 1992 | A |
5616140 | Prescott | Apr 1997 | A |
5824023 | Anderson | Oct 1998 | A |
5913883 | Alexander et al. | Jun 1999 | A |
6045575 | Rosen et al. | Apr 2000 | A |
6290713 | Russell | Sep 2001 | B1 |
6293900 | Bove et al. | Sep 2001 | B1 |
6350275 | Vreman | Feb 2002 | B1 |
6443978 | Zharov | Sep 2002 | B1 |
6471716 | Pecukonis | Oct 2002 | B1 |
6508813 | Altshuler | Jan 2003 | B1 |
6511475 | Altshuler et al. | Jan 2003 | B1 |
6517532 | Altshuler et al. | Feb 2003 | B1 |
6689380 | Marchitto | Feb 2004 | B1 |
6743249 | Alden | Jun 2004 | B1 |
6824265 | Harper | Nov 2004 | B1 |
6860896 | Leber | Mar 2005 | B2 |
6908195 | Fuller | Jun 2005 | B2 |
7125416 | Kent et al. | Oct 2006 | B2 |
7222995 | Bayat et al. | May 2007 | B1 |
7438409 | Jordan | Oct 2008 | B2 |
7520630 | Murphy | Apr 2009 | B2 |
7824241 | Duprey | Nov 2010 | B2 |
7896908 | Ripper | Mar 2011 | B2 |
7943811 | Da Silva Macedo, Jr. | May 2011 | B2 |
8192473 | Tucker et al. | Jun 2012 | B2 |
8252033 | Tucker et al. | Aug 2012 | B2 |
8491118 | Waters | Jul 2013 | B2 |
8771328 | Tapper et al. | Jul 2014 | B2 |
8858607 | Jones | Oct 2014 | B1 |
20030009205 | Biel | Jan 2003 | A1 |
20030199800 | Levin | Oct 2003 | A1 |
20040162549 | Altshuler | Aug 2004 | A1 |
20050070977 | Molina | Mar 2005 | A1 |
20050080465 | Zelickson et al. | Apr 2005 | A1 |
20050182460 | Kent | Aug 2005 | A1 |
20050278003 | Feldman | Dec 2005 | A1 |
20060173514 | Biel et al. | Aug 2006 | A1 |
20060217690 | Bastin et al. | Sep 2006 | A1 |
20060217787 | Olson | Sep 2006 | A1 |
20060268220 | Hogan | Nov 2006 | A1 |
20070156208 | Havell et al. | Jul 2007 | A1 |
20070208395 | Leclerc et al. | Sep 2007 | A1 |
20070233208 | Kurtz et al. | Oct 2007 | A1 |
20070239232 | Kurtz | Oct 2007 | A1 |
20080058915 | Chang | Mar 2008 | A1 |
20080065056 | Powell et al. | Mar 2008 | A1 |
20080269849 | Lewis | Oct 2008 | A1 |
20090143842 | Cumbie et al. | Jun 2009 | A1 |
20090192437 | Soltz et al. | Jul 2009 | A1 |
20100023927 | Yang | Jan 2010 | A1 |
20100069898 | O'Neil et al. | Mar 2010 | A1 |
20100121254 | McDaniel | May 2010 | A1 |
20100121419 | Douglas | May 2010 | A1 |
20110015707 | Tucker et al. | Jan 2011 | A1 |
20110040355 | Francis | Feb 2011 | A1 |
20110160814 | Tucker et al. | Jun 2011 | A2 |
20110257467 | Clegg et al. | Oct 2011 | A1 |
20120116485 | Burgmann | May 2012 | A1 |
20120323064 | Kim | Dec 2012 | A1 |
Number | Date | Country |
---|---|---|
1738663 | Feb 2006 | CN |
20 20009 000 891 | Jul 2009 | DE |
1 074 275 | Feb 2001 | EP |
1 916 016 | Apr 2008 | EP |
2 380 134 | Apr 2003 | GB |
WO2004052238 | Dec 2003 | WO |
WO 2006028461 | Mar 2006 | WO |
WO 2010076707 | Jul 2010 | WO |
WO2011049419 | Oct 2010 | WO |
Entry |
---|
PCT/US2014/069789—PCT Notification Concerning Transmittal of Int'l Preliminary Report on Patentability dated Jun. 23, 2016 (Johnson & Johnson Consumer, Inc.). |
PCT/US2016/038606—PCT Notification Concerning Transmittal of Int'l Preliminary Report on Patentability dated Nov. 15, 2016 (Johnson & Johnson Consumer, Inc.). |
PCT/US2016/038607—PCT Notification Concerning Transmittal of Int'l Preliminary Report on Patentability dated Sep. 29, 2016 (Johnson & Johnson Consumer, Inc.). |
PCT/US2016/038608—PCT Notification Concerning Transmittal of Int'l Preliminary Report on Patentability dated Sep. 29, 2016 (Johnson & Johnson Consumer, Inc.). |
PCT/US2016/038612—PCT Notification Concerning Transmittal of Int'l Preliminary Report on Patentability dated Sep. 29, 2016 (Johnson & Johnson Consumer, Inc.). |
PCT/US2014035009; Extended European Search Report; 8 pages, J&J Consumer Inc., Munich, Dec. 14, 2016. |
Number | Date | Country | |
---|---|---|---|
20150290470 A1 | Oct 2015 | US |
Number | Date | Country | |
---|---|---|---|
61791738 | Mar 2013 | US | |
61532140 | Sep 2011 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 13604012 | Sep 2012 | US |
Child | 14324453 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 14212601 | Mar 2014 | US |
Child | 14747687 | US | |
Parent | 14324453 | Jul 2014 | US |
Child | 14212601 | US |